Comparative effectiveness of lipid-lowering treatments to reduce cardiovascular disease
{{output}}
Introduction: The proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor is a new treatment option for patients with hypercholesterolemia. The objective of this study was to systematically review the cost-effectiveness o... ...
